Stroke
Conference Coverage
Novel celery seed–derived drug may improve stroke outcomes
Patients treated with butylphthalide had fewer severe neurologic symptoms and better function 90 days after the stroke, compared with those...
Conference Coverage
Drug combo promising in vascular cognitive impairment: LACI-2 trial results
The drugs – isosorbide monoitrate and cilostazol – stabilize endothelial function, which is a new therapeutic target for patients with small-...
Conference Coverage
Tenecteplase noninferior to alteplase for ischemic stroke: TRACE-2
“The results provide further evidence to support a worldwide switch to tenecteplase as the preferred thrombolytic for acute ischemic stroke.”
Conference Coverage
Thrombectomy benefits stroke with large core volumes: SELECT2 trial results
Study findings may change clinical practice and the way in which systems of stroke care are organized.
Conference Coverage
Blood pressure lowering after thrombectomy may be harmful
Using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg after thrombectomy may not be beneficial.
Conference Coverage
STROKE AF at 3 years: High AFib rate after atherosclerotic stroke
Continuous monitoring to detect AFib should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke...
Conference Coverage
Novel neuroprotective agent promising in stroke
New findings illustrate that it is possible to improve outcomes for stroke patients “not only with reperfusion therapy but with neuroprotectants...
From the Journals
AHA scientific statement on rapid evaluation for suspected TIA
A key aim of the statement is to help clinicians properly risk-stratify patients with suspected TIA.
Feature
Renowned stroke expert Ralph L. Sacco, MD, dies
Dr. Sacco, the only physician to have served as president of both the American Heart Association and American Academy of Neurology, was 65.
From the Journals
Is thrombolysis safe for stroke patients on DOACs?
“Our results suggest that current guidelines need to be revised to remove the absolute contraindication of thrombolysis in patients on DOACs.”
From the Journals
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...